Concerns are growing for the future of the workforce in Cashel’s Ranbaxy pharmaceutical plant on the Cahir road.
Staff were called to a meeting with management on Thursday morning last week to discuss the future of the site. Nearly 100 people work at the factory which manufactures and packages generic drugs.
In March, the world’s fifth largest drugs producer Sun Pharma completed a merger with fellow Indian company Ranbaxy, which included the Cashel plant.
The company is seeking to re-organise its global operations with a view to optimising its costs and overall capacity. The company has stated its intention scale down or divest itself of certain operations worldwide.
According to a spokesman for Sun Pharma, the Cashel site has been earmarked as one of those locations chosen to be either sold or divested in the coming months. It’s understood the fate of the plant will be known for certain in the New Year.
Full story in this week’s Tipperary Star. P46